Pluripotent lymphohematopoietic stem cells are probably confined to bone marrow cells expressing CD34 surface molecules. To investigate the capacity of adult human CD34 § bone marrow cells to differentiate along the T lymphoid lineage, we plated purified CD34 + cells from healthy adults in liquid culture on adherent thymic stromal cells prepared from HLA-or blood group-mismatched postnatal thymic tissue. We show that purified CD34 + CD3-CD4-CD8-bone marrow cells contained progenitors with the ability to differentiate into CD4 + and CD8 + T lymphocytes expressing surface (s)CD3 and T cell receptor ot//~ in vitro. These progenitors were found in the CD34 + CD2 + sCD3 -CD4-CD8 -, CD34 + CD7 + sCD3 -CD4 -CD8 -, and CD34 + CD2 § CD7 + sCD3-CD4-CDS-, as well as in the CD34 + CD2-sCD3-CD4-CD8-, CD34 + CD7-sCD3-CD4-CD8-, and CD34 + CD2-CD7-sCD3-CD4-CD8-subsets, indicating that T lymphocyte progenitors sensitive to signals mediated by thymic stroma in vitro are not restricted to CD34 + cells already coexpressing early T lymphocyte-associated markers. Finally, we show that T lymphopoiesis was enhanced by c-kit ligand.
B
one marrow cells expressing CD34 surface molecules constitute "~1% of low density nucleated bone marrow cells (1) . There are several observations to suggest that CD34 § cells include pluripotent stem cells (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In mice, T lymphopoiesis can be demonstrated by transfer of bone marrow cells into irradiated hosts, and differentiation to mature human T lymphocytes from liver-derived fetal hematopoietic progenitors is observed in the Thy SCID-human (hu) 1 mouse (13) (14) (15) (16) . Recently, P6ault et al. (17) have succeeded in reconstituting T lymphopoiesis in fetal thymus in SCID-hu mice with fetal human CD34 + cells. In these experiments T lymphocyte differentiation was accomplished in thymus in vivo. Maintenance of the thymic microenvironment has been claimed to be a prerequisite for differentiation of stem cells into mature T lymphocytes (17) .
The aim of this study was to investigate whether postnatal human CD34 § bone marrow cells can give rise to T lymphocyte differentiation in vitro, and whether full differentiation to mature T lymphocytes can be accomplished. This study shows that when cultured on thymic stroma, a population of human CD34 + bone marrow cells devoid of the surface (s) molecules CD3, CD4, and CD8 can be directed into T lymphopoiesis in vitro, as ascertained by the appearance of cells expressing CD3, CD4, CDS, and TCR ot/~ surface Thymic tissue specimens were obtained from two children <6 mo of age undergoing median sternotomy and corrective cardiovascular surgery (kindly provided by H. Lindberg, Surgical Department A, The National Hospital, Oslo, Norway). One donor was HLA-A2+,AKh +, and the other was HLA-A2-,ORh + . The thymic tissue was transported to the laboratory in HBSS (Gibco) with penicillin and streptomycin. The thymic tissue was minced into pieces, and single cells were eluted in HBSS with collagenase (0.5 mg/ml) (Sigma Chemical Co., St. Louis, MO) and DNase I (1 /~g/ml) (Sigma Chemical Co.) at 37~ under continuous shaking for 1.5 h. After six to eight repeated cycles of elution the thymic tissue was totally disintegrated. Single cell suspensions from the last three to four eluates were washed twice and resuspended in RPMI 1640 (Gibco) with penicillin and streptomycin before cryopreservation.
Antibodies. The following mAbs were used for flow cytometry:
FITC-labeled anti-Leu-Sb (CD2), anti-Leu-4 (CD3), anti-Leu-9 (CD7), and anti-HPCA-2 (8G12, CD34), and PE-labeled anti-HPCA-2, anti-Leu-M7 (CD13), Simultest CD4/CD8 (anti-Leu-3a FITC + anti-Leu-2a PE), Simultest LeukoGATE (anti-HLe-1 FITC + anti-Leu-M3 PE), and Simultest control (IgG1 FITC + IgG2a PE) (Becton Dickinson Immunocytometry Systems [BDIS], Mountain View, CA). PE-labeled anti-CD2, and anti-CD34 (ICH3) were purchased from Caltag Laboratories, Inc. (South San Francisco, CA), anti-TCK o~/~ (BMA031) from Behringwerke AG (Marburg, Germany), and anti-CD3 (101.1) from Novo Research Institute (Copenhagen, Denmark). Anti-HLA-A2 (ITI-8G12) was developed in our own laboratory by G. Gaudernack. Anti-A (blood group A) was purchased from Lorne Laboratories Ltd. (England). FITC-labeled anti-Leu-Sb and anti-Leu-9 and PE-labeled anti-HPCA-2 from BDIS were used for cell sorting by flow cytometry. The following mAbs were used for immunoftuorescence: TE-7, reactive with nonkeratinized, mesodermal-derived thymic fibrous stroma, and TE-15, reactive with Hassell's bodies (a kind gift from K. H. Singer, Duke University School of Medicine, Durham, NC) (21) . Fluoresceinated goat anti-mouse isotype-and subclass-specific polyclonal antibodies were purchased from Southern Biotechnology Associates, Inc. (Birmingham, AL).
Culture Assays. After thawing, eluted thymic cells were washed twice, resuspended in CM, and plated, with 2 x 106 cells/well in 24-well tissue culture plates (Costar, Cambridge, MA). The cells were cultured in a humidified atmosphere of 5% CO2 in air at 37~ for 6-8 d to establish a confluent layer of adherent cells. Supernatants were collected, filtered, and frozen for later use. Nonadherent cells were removed from the wells by repeated washing.
CD34 § cells were plated on the adherent thymic stromal cells, with 10 s cells/well in 1 ml CM with 10% (vol/vol) thymic stromal cell supernatant, and with four to five wells per series. The cells were cultured in the absence or presence of recombinant murine (rm) c-kit ligand (2 U/ml) (a kind gift from S. C. Clark, Genetics Institutes, Cambridge, MA). Media were half changed with fresh supernatant media twice weekly, rmc-kit ligand was added according to protocol. Nonadherent cells were harvested after 14 and 28 d, enumerated in a B/irker chamber, and analyzed by flow cytometry.
To more closely identify prethymic T lymphocyte progenitors, flow cytometry-sorted CD34+CD2 +, CD34+CD7 +, CD34 + CD2+CD7 +, CD34 § -, CD34+CD7 -, and CD34+CD2 -CD7-cells (2,500--5,000 cells/well) were cultured on thymic stromal cells in the presence of rmc-kit ligand, with two to three wells per series. Nonadherent cells were harvested, enumerated, and phenotyped by flow cytometry after 21 d.
Bone marrow cells from the nonCD34 + fraction (i.e., bone marrow cells not rosetting with BI-3C5-coated Dynabeads), CD4 § T lymphocytes, or CD8 § T lymphocytes (10 s cells/well) were also cultured under the same conditions. To study the necessity of thymic stroma to support T lymphopoiesis, adherent cells prepared from MRC-5 (a flbroblast cell line), Hep-2 (a hepatoma cell line), and allogeneic peripheral blood monocytes, and nonadherent allogeneic Epstein-Barr blasts were substituted for thymic stromal cells. Furthermore, CD34 + cells were cultured in 96-well U-bottomed tissue culture plates (Costar), with 1,000 cells/well in 200/zl CM, in the presence of irradiated allogeneic PBMC, PHA (1/zg/ml) (Wdcome, Dartford, England), and rlL-2 (10 U/ml) (Genzyme, Cambridge, MA). The cultures were restimulated with irradiated allogeneic PBMC, PHA, and rib2 after 7 d and cultured for an additional 8 d. The cells were cultured for the last 18 h in the presence of 10/zM [3H]thymidine (2 Ci/mmol), harvested on filter mats, and counted using a scintillation counter (LKB Instruments, Turku, Finland). Non-CD34 § bone marrow cells and PBMC served as positive controls, and irradiated PBMC served as negative control.
Flow Cytometry and Cell Sorting. Cell staining was performed according to the manufacturer's instructions and the cells were resuspended in HBSS with 1% paraformaldehyde. Flow cytometry analyses were performed on a FACScan | with the FACScan | Research Software (BDIS). 50,000 events were acquired and stored in list mode files.
Cell sorting was performed on an Epics Elite (Coulter Electronics, Hialeah, FL). Cells were sorted at a rate of 800-1,000 cells/s. A sort gate within a dual parameter cytogram of forward light scatter against 90 ~ side scatter was drawn. A second amorphous gate was drawn on the two-color cytograms shown (Fig. 6 ). Sort equations were set to positively sort cells satisfying both gates.
Immunofluorescence Microscopy. To investigate the identity of the adherent cell layer, the adherent cells were fixed in ethanol, incubated with the mAbs for 30 min at room temperature, washed twice, and incubated with a goat anti-mouse fluoresceinated antibody.
Limiting Dilution Assays. To examine the T lymphocyte precursor frequency of CD34 + cells expressing the CD2 and CD7 markers and CD34 + cells devoid of these markers, we performed experiments in limiting dilution assays. Allogeneic adherent thymic stromal cells were established in 96-well flat-bottomed tissue cultures plates (Costar) as described above. CD34+CD2 ~, CD34+CD7 +, CD34+CD2 -, and CD34+CD7 -cells were plated with CM supplemented with rmc-kit ligand (2 U/ml) and 10% (vol/vol) thymic stromal cell supernatant at 15-240 cells/well with 20 replicates per concentration. Media were doubled at day 5 and then half changed with fresh rmc-kit ligand and supematant media twice weekly until week 3. Wells were harvested and the calls phenotyped by an immunomagnetic method (22) . Dynabeads M-450 (Dynat) coupled with a mAb against CD3 (38,1; kindly provided byJ. A. Hansen, Fred Hutchinson's Cancer Research Center, Seattle, WA) were selected for detection ofT lymphocytes in the cultures. Wells were determined positive for T lymphocytes when >5% of the cells made rosettes with more than five beads and the rosetting cells were small lymphoid cells. Based on Taswell's equation, the frequency of T lymphocyte progenitors was calculated (23) .
Statistics. The growth abilities of CD34 § cells in the absence and presence of rmc-kit ligand were compared using the Student's t test for paired observations.
Results

Characterization of Isolated CD34 + Cells. The immunomagnetically isolated cells contained >90% CD34 § cells in
all experiments and >95% in most experiments. The flow cytometry-sorted cells contained >98% CD34 + cells in all experiments. Cells expressing CD3 surface molecules could not be detected by flow cytometry (Fig. 1) , and neither could cells expressing CD4 or CD8 molecules (not shown). "'e. ", ", r "" ""'." -r -.
Preparation of an Adherent Layer of T~mic Stromal Cells
"" "~" ",i/~" "~/~" "66o" isbo FSC The growth ability of CD34 + cells. Table i shows the relative number of cells expressing CD34-and T lymphocyte-associated surface molecules of the progeny of the CD34+sCD3-CD4-CD8 -cells after 28 
there were no differences between the relative numbers of cells expressing the different surface molecules analyzed after 14 and 28 d. CD34 expression was mainly confined to cells in the R2 fraction ( Fig. 3 and Table 1 ). On the other hand, cells expressing the CD2, CD7, CD3, CD4, and CD8 molecules were mainly confined to the R1 fraction (Fig. 4 and Table 1 ). The majority of sCD3 § cells in K1 fraction coexpressed TCK or~f3 (Fig. 4) . The low numbers of CD4 + CD8 § cells cannot account for the high numbers of sCD3 § TCR ot/B + cells demonstrated after culture (Fig. 5, B, C , and E). Although not demonstrated in a triple-color cytogram, most if not all CD4 + and CD8 + cells had to be There were no differences in distribution of T lymphocyteassociated markers whether the progeny were derived from CD34 + cells, CD34 § cells after CD19, CD4, and CD8 depletion, or CD34 + cells cultured in the absence or presence of rmc-kit ligand.
The T lymphocytes emerging after culture could be demonstrated to be of bone marrow donor origin by coexpression of bone marrow donor-specific HLA or blood group molecules and sCD3 (Fig. 4) .
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T Lymphocyte Progenitors. A minor proportion of
CD34+sCD3-CD4-CD8 -cells was found to coexpress the CD2 and/or CD7 molecule (1-2%) (Fig. 6 ). When cultured in bulk, these subsets gave rise to lymphoid cells of T lymphocyte lineage just like unfractionated CD34 + cells (Figs. 4 and 5 ). To examine whether T lymphocyte precursors were exclusively confined to the CD34+CD2 +, CD34+CD7 § and CD34+CD2 § + subsets, CD34 + CD2-, CD34 § CD7-, and CD34 § CD2-CD7-cells were cultured under the same conditions. The results of these experiments dearly demonstrate that even CD34 § cells devoid of the T lymphoid markers CD2 and/or CD7 contained T lymphocyte progenitors with the ability to proliferate and differentiate into T lympbocytes when cultured on thymic stroma in vitro. However, apart from giving rise to T lymphocyte differentiation, both CD34+CD2 § and CD34 § CD7 + cells (and the other subsets studied) also contained progenitors able to differentiate into the myeloid lineage, as ascertained by detection of cells expressing CD13 and CD14 after culture (data not shown).
To examine whether any of the subsets of CD34 + cells studied in bulk cultures were enriched for T lymphocyte precursors, limiting dilution analyses were performed. The precursor frequency of CD34+CD2 + cells was found to be 1:13; CD34 § -cells, 1:18; CD34+CD7 + cells, 1:9; and CD34+CD7 -cells, 1:8. Accordingly, none of the subset investigated were found to be enriched for T lymphocyte precursors. However, given the level of progenitors revealed by the limiting dilution analyses, contaminating mature T lymphocytes, <1% according to flow cytometry, cannot account for appearance of T lymphocytes after culture.
Discussion
T lymphopoiesis from human fetal hematopoietic stem ceils has been demonstrated in vivo in the Thy SCID-hu mouse model (15) (16) (17) . Furthermore, T lymphopoiesis from fetal human CD10 + bone marrow cells and from mouse hematopoietic stem cells has been achieved in vitro (24, 25) . T lymphopoiesis from adult human prethymic CD34 + bone marrow cells has been demonstrated neither in vivo nor in vitro. The present study demonstrates that T lymphopoiesis from adult human CD34 + bone marrow cells can be accomplished in vitro. After culture of CD34+sCD3-CD4 -CD8-cells for 14 and 28 d on allogeneic thymic stromal cells, cells of bone marrow donor origin with characteristics of lymphoid cells expressing the phenotype of mature T lymphocytes were demonstrated.
It was necessary to exclude the possibility that the purified CD34 + cells contained mature T lymphocytes, the expansion of which could account for the T lymphocytes demonstrated. We are confident that this was not the case. First, no mature T lymphocytes (sCD3 + cells) were detected by flow cytometric analyses of purified CD34 + cells 9 Contaminating cells were almost exclusively small agranular cells with the phenotype of mature B lymphocytes (CD34-CD19+CD37 +) (19, 26) . Second, culture of non-CD34 § bone marrow cells, which contained large numbers of mature T lymphocytes, did not result in any cell multiplication, nor did cultures of CD4 + nor CD8 + T lymphoeytes. Third, CD34 + cells did not proliferate after stimulation with irradiated allogeneic PBMC, PHA, and rlL-2. In addition, we have previously demonstrated lack of generation of cells expressing T lymphocyte-restricted markers after stimulation of purified CD34 + cells with PHA and rlL-2 (27) . This is in accordance with the finding that CD7 § -human thymic and bone marrow cells do not respond to PHA and/or rlL-2 (28, 29) . Fourth, after depletion with mAbs against CD4CD8 and CD19CD34 + cells still gave rise to T lymphocytes. Fifth, the finding of CD4 + CD8 + cells cannot be explained by contamination of mature T lymphocytes among the purified CD34 § cells. Last, limiting dilution analyses demonstrated T lymphocyte precursor frequency of 1:8-18 in sorted CD34 § cells. Thus, outgrowth of rare contaminating mature T lymphocytes, <1% according to flow cytometry, cannot account for the appearance of CD4 + and CD8 + cells after culture.
We have presented evidence that when cultured on thymic stroma, CD34 § human bone marrow cells proliferate and differentiate along the T lymphoid lineage. It might be argued that the single-positive CD4 + and CD8 + cells observed after culture could correspond to immature singlepositive (i.e., preCD4 + CD8 +) cells and not mature CD4 + and CD8 + cells. In the presence of IL-7, highly purified human triple-negative thymocytes can proliferate and differentiate to express CD4 and/or CD8(ot +/3-). These cells, which remain CD3-, are thought to precede the common cortical double-positive thymocytes that are CD31~ + CDSot+/3 + (29). In our study, the demonstration of CD3bnghtTCR c~/3 § cells cannot be accounted for by the low number of CD4+CD8 § cells detected. Accordingly, most, if not all, CD4 + and CD8 + cells have to be CD3+TCR oe/3 + . Based on this, we are entitled to state that CD34 § adult human bone marrow cells when cultured on thymic stroma possess the ability to proliferate and differentiate into mature CD4 +CD3 +TCR c~/3 + and CD8 +CD3 § TCR ce/3 + T lymphocytes. The functional ability of these CD4 + and CD8 + T lymphocytes will be addressed in ongoing studies.
It is generally accepted that development of T lymphocytes from early thymocytes (sCD3-CD4-CD8-) involves a stage of CD4+CD8 + cells preceding the appearance of sCD3+CD4 + and sCD3+CD8 + T lymphocytes. CD4 + CD8 + cells were present at day 14, but they were hardly detectable at day 28. This suggests that maturation to sCD3 + CD4 + and sCD3 + CD8 + lymphocytes took place through an intermediate stage of CD4 + CD8 + ceils in this in vitro assay as well.
We found that a large majority of T lymphocytes devdoping when adult human CD34 + bone marrow cells were cultured on thymic stroma expressed TCR or/3. This is in contrast to previous reports that postnatal sCD3-CD4-CD8-thymic T lymphocyte precursors develop nearly exclusively into TCR q,/~+ cells in cultures without feeder cells (30) .
However, fetal sCD3-CD4-CD8-thymic T lymphocyte precursors develop into TCR ot/~ § cells (31, 32) . Human T lymphocytes found in the peripheral blood of SCID-hu (fetal thymus and liver) mice express TCR a/3 (33) . Finally, hematopoietic stem cells in the Go phase from adult mice differentiate into T lymphocytes expressing TCR 3 chains in an in vitro organ culture assay with fetal thymic tissue (25) . Taken together with the present results, this suggests that thymic stroma is necessary for the development of T lymphocytes expressing TCR o#3 from postnatal progenitors. This notion is further supported by another report showing that thymic stromal cells are required for the development of both or//3 and 3d/$ T lymphocytes from postnatal CD7 + CD45 + CD1 -CD2-CD3-CD4-CD8-early thymocytes (34) . In previous studies where T lymphopoiesis from hematopoietic stem cells was achieved, the three-dimensional structure of the thymic microenvironment was maintained (16, 17, 25) . Our studies confirm the necessity of thymic stroma, but the maintenance of the three-dimensional structure is not always necessary. In the absence of thymic stroma we were not able to obtain T lymphocyte differentiation when CD34 + cells were cultured in the presence of several combinations of growth factors (rlL-1, rlL-2, rlL-3, rlL-7, GM-CSF, and rmc-kit ligand) or supernatant from thymic stromal cells (27, Steen, R., L. Mcrkrid, G. E. Tjcnnijord, and T. Egeland, manuscript submitted for publication, and unpublished observations).
Human CD34 + cells are phenotypically heterogeneous with subsets coexpressing lineage-specific markers. CD7 and CD2 are believed to be expressed by prethymic pre-T cells (7, 11, 12, 31, 35, 36) . Therefore, the ability of CD34+CD2 +, CD34+CD7 +, CD34+CD2+CD7+, CD34+CD2 -, CD34 § -, and CD34+CD2-CD7 -bone marrow cells to differentiate into T lymphocytes was studied in the same assay. Progenitors able to support T lymphophoiesis in vitro were found in all of these subsets. Furthermore, limiting dilution analyses did not demonstrate enrichment of T lymphocyte precursors in any of these subsets. The inability to demonstrate an enrichment for T lymphocyte precursors among different subsets of CD34 + cells may reflect thymus-dependent negative selection and apoptosis. This may be the rate-limiting step even in this in vitro assay and may preclude the finding of a possible difference in T lymphocyte precursor frequency of the subsets studied. In vivo, surface molecules like leukocyte endothelial cell adhesion molecule 1 (LECAM-1) known to be expressed by CD34+CD2+CD7 + bone marrow cells, may be involved in homing of these cells to thymus (12) . The concept of homing is bypassed in this in vitro assay, and this as well as other culture-associated phenomena may account for our inability to demonstrate a difference in precursor frequency between different subsets of CD34 + cells.
CD34+CD7 § and CD34+CD2 § sCD3-CD4-CD8-cells as well as the other subsets studied were multipotent since they were capable of giving rise to myeloid progeny. This corresponds with the demonstration of differentiation into nonlymphoid lineages of human thymic CD7 § sCD3-CD4-CD8-T lymphocyte precursors by IL-3, Epo, G-CSF, M-CSF, GM-CSF, and factors produced by thymic epithdial (TE) cells (37) .
Both purified native and rc-kit ligand show synergistic actions with other factors on whole bone marrow and isolated CD34 + human cells such as IL-3, IL-1, IL-6, G-CSF, GM-CSF, and Epo in various assays (38) (39) (40) , and Steen, R., L. Mcrkrid, G. E. Tjcnnfjord, and T. Egeland, manuscript submitted for publication). The results presented here show that rmc-kit ligand strongly potentiated the cell multiplication in this assay without changing the phenotypic profile of the progeny. This supports the view that the synergistic effect of rmc-kit ligand on growth factors also includes growth factors neccessary for T lymphopoiesis.
In the present study we show that purified CD34 + sCD3-CD4-CD8-bone marrow cells from healthy adults contained progenitors with the ability to proliferate and differentiate into CD3 + CD4 + or CD3 + CD8 + T lymphocytes expressing TCR ot//~ in vitro. The presence of thymic stromal cells seemed to be a prerequisite for T lymphopoiesis to be accomplished from bone marrow progenitors. T lymphocyte progenitors were found both among CD34 + cells expressing CD2 or CD7 surface markers and CD34 + cells devoid of these markers. Furthermore, c-kit ligand enhanced T lymphopoiesis.
